Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

August 30, 2016

Study Completion Date

October 30, 2016

Conditions
Cancer LarynxTotal Laryngectomy
Interventions
DRUG

Propofol group

Anesthesia is maintained with continuous infusion of propofol 1.5-2mg/kg/h and dexmedetomidine 0.2-1ug/kg/h.

DRUG

Isoflurane group

Anesthesia was maintained with isoflurane at a concentration of 2-2.5%. fentanyl 50 ug increments

Trial Locations (1)

050

Mansoura University Hospitals, Ear Nose Thorat Department, Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT02739958 - Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx | Biotech Hunter | Biotech Hunter